PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical assessment is poor, scoring 1/10. Both Long Lower Shadow and Long Upper Shadow generate bearish signals with win rates below 30% and average returns around –6% to –7%. No bullish indicators appear, indicating heightened downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score1/10
Win Rate29.23%
Hist. Signals65
Avg Return-5.71%
Score1/10
Win Rate29.23%
Hist. Signals65
Avg Return-5.71%
Long Upper Shadow
Score1/10
Win Rate28.30%
Hist. Signals53
Avg Return-7.52%
Score1/10
Win Rate28.30%
Hist. Signals53
Avg Return-7.52%
Long Lower Shadow
Score1/10
Win Rate29.23%
Hist. Signals65
Avg Return-5.71%
Score1/10
Win Rate29.23%
Hist. Signals65
Avg Return-5.71%
Long Upper Shadow
Score1/10
Win Rate28.30%
Hist. Signals53
Avg Return-7.52%
Score1/10
Win Rate28.30%
Hist. Signals53
Avg Return-7.52%
What is the current technical signals for PPCB?
- PPCB presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 31.81 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 0.18. Traders should monitor key support at 0.10 and resistance at 0.11.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
